Cargando…

Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals

The study aimed to develop cisplatin-loaded PEGylated chitosan nanoparticles. The optimal batch of cisplatin-loaded PEGylated chitosan nanoparticles had a + 49.9 mV zeta potential, PDI of 0.347, and % PDI of 58.9. Nanoparticle zeta size was 741.4 z. d.nm, the size in diameter was 866.7 ± 470.5 nm, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sultan, Muhammad H., Moni, Sivakumar S., Alqahtani, Saad S., Ali Bakkari, Mohammed, Alshammari, Abdulrahman, Almoshari, Yosif, Alshahrani, Saeed, Madkhali, Osama A., Mohan, Syam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203781/
https://www.ncbi.nlm.nih.gov/pubmed/37228326
http://dx.doi.org/10.1016/j.jsps.2023.04.005
_version_ 1785045705279143936
author Sultan, Muhammad H.
Moni, Sivakumar S.
Alqahtani, Saad S.
Ali Bakkari, Mohammed
Alshammari, Abdulrahman
Almoshari, Yosif
Alshahrani, Saeed
Madkhali, Osama A.
Mohan, Syam
author_facet Sultan, Muhammad H.
Moni, Sivakumar S.
Alqahtani, Saad S.
Ali Bakkari, Mohammed
Alshammari, Abdulrahman
Almoshari, Yosif
Alshahrani, Saeed
Madkhali, Osama A.
Mohan, Syam
author_sort Sultan, Muhammad H.
collection PubMed
description The study aimed to develop cisplatin-loaded PEGylated chitosan nanoparticles. The optimal batch of cisplatin-loaded PEGylated chitosan nanoparticles had a + 49.9 mV zeta potential, PDI of 0.347, and % PDI of 58.9. Nanoparticle zeta size was 741.4 z. d.nm, the size in diameter was 866.7 ± 470.5 nm, and nanoparticle conductivity in colloidal solution was 0.739 mS/cm. Differential scanning calorimetry (DSC) revealed that cisplatin-loaded PEGylated chitosan nanoparticles had sharp endothermic peaks at temperatures at 168.6 °C. The thermogravimetric analysis (TGA) showed the weight loss of cisplatin-loaded PEGylated chitosan nanoparticles, which was observed as 95% at 262.76 °C. XRD investigation on cisplatin-loaded PEGylated chitosan nanoparticles exhibited distinct peaks at 2θ as 9.7°, 20.4°, 22.1°, 25.3°, 36.1°, 38.1°, 39.5°, 44.3°, and 64.5°, confirming crystalline structure. The (1)H NMR analysis showed the fingerprint region of cisplatin-loaded PEGylated chitosan nanoparticles as 0.85, 1.73, and 1.00 ppm in the proton dimension and de-shielded proton peaks appeared at 3.57, 3.58, 3.58, 3.59, 3.65, 3.67, 3,67, 3,67, 3.70, 3.71, 3.77, 3.78 and 4.71 ppm. The (13)C NMR spectrum showed specified peaks at 63.18, 69.20, and 70.77 ppm. The FT-IR spectra of cisplatin loaded PEGylated nanoparticles show the existence of many fingerprint regions at 3186.52, 2931.68, 1453.19, 1333.98, 1253.71, 1085.19, 1019.60, 969.98, 929.53, 888.80, 706.13, and 623.67 cm(−1). The drug release kinetics of cisplatin loaded PEGylated chitosan nanoparticles showed zero order kinetics with 48% of drug release linearity fashion which has R(2) value of 0.9778. Studies on the MCF-7 ATCC human breast cancer cell line in vitro revealed that the IC50 value 82.08 µg /mL. Injectable nanoparticles had good physicochemical and cytotoxic properties. This method is novel since the application of the PEGylation processes leads to an increased solubility of chitosan nanoparticles at near neutral pH.
format Online
Article
Text
id pubmed-10203781
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102037812023-05-24 Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals Sultan, Muhammad H. Moni, Sivakumar S. Alqahtani, Saad S. Ali Bakkari, Mohammed Alshammari, Abdulrahman Almoshari, Yosif Alshahrani, Saeed Madkhali, Osama A. Mohan, Syam Saudi Pharm J Original Article The study aimed to develop cisplatin-loaded PEGylated chitosan nanoparticles. The optimal batch of cisplatin-loaded PEGylated chitosan nanoparticles had a + 49.9 mV zeta potential, PDI of 0.347, and % PDI of 58.9. Nanoparticle zeta size was 741.4 z. d.nm, the size in diameter was 866.7 ± 470.5 nm, and nanoparticle conductivity in colloidal solution was 0.739 mS/cm. Differential scanning calorimetry (DSC) revealed that cisplatin-loaded PEGylated chitosan nanoparticles had sharp endothermic peaks at temperatures at 168.6 °C. The thermogravimetric analysis (TGA) showed the weight loss of cisplatin-loaded PEGylated chitosan nanoparticles, which was observed as 95% at 262.76 °C. XRD investigation on cisplatin-loaded PEGylated chitosan nanoparticles exhibited distinct peaks at 2θ as 9.7°, 20.4°, 22.1°, 25.3°, 36.1°, 38.1°, 39.5°, 44.3°, and 64.5°, confirming crystalline structure. The (1)H NMR analysis showed the fingerprint region of cisplatin-loaded PEGylated chitosan nanoparticles as 0.85, 1.73, and 1.00 ppm in the proton dimension and de-shielded proton peaks appeared at 3.57, 3.58, 3.58, 3.59, 3.65, 3.67, 3,67, 3,67, 3.70, 3.71, 3.77, 3.78 and 4.71 ppm. The (13)C NMR spectrum showed specified peaks at 63.18, 69.20, and 70.77 ppm. The FT-IR spectra of cisplatin loaded PEGylated nanoparticles show the existence of many fingerprint regions at 3186.52, 2931.68, 1453.19, 1333.98, 1253.71, 1085.19, 1019.60, 969.98, 929.53, 888.80, 706.13, and 623.67 cm(−1). The drug release kinetics of cisplatin loaded PEGylated chitosan nanoparticles showed zero order kinetics with 48% of drug release linearity fashion which has R(2) value of 0.9778. Studies on the MCF-7 ATCC human breast cancer cell line in vitro revealed that the IC50 value 82.08 µg /mL. Injectable nanoparticles had good physicochemical and cytotoxic properties. This method is novel since the application of the PEGylation processes leads to an increased solubility of chitosan nanoparticles at near neutral pH. Elsevier 2023-06 2023-04-13 /pmc/articles/PMC10203781/ /pubmed/37228326 http://dx.doi.org/10.1016/j.jsps.2023.04.005 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Sultan, Muhammad H.
Moni, Sivakumar S.
Alqahtani, Saad S.
Ali Bakkari, Mohammed
Alshammari, Abdulrahman
Almoshari, Yosif
Alshahrani, Saeed
Madkhali, Osama A.
Mohan, Syam
Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals
title Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals
title_full Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals
title_fullStr Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals
title_full_unstemmed Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals
title_short Design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded PEGylated chitosan injectable nano / sub-micron crystals
title_sort design, physicochemical characterisation, and in vitro cytotoxicity of cisplatin-loaded pegylated chitosan injectable nano / sub-micron crystals
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203781/
https://www.ncbi.nlm.nih.gov/pubmed/37228326
http://dx.doi.org/10.1016/j.jsps.2023.04.005
work_keys_str_mv AT sultanmuhammadh designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT monisivakumars designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT alqahtanisaads designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT alibakkarimohammed designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT alshammariabdulrahman designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT almoshariyosif designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT alshahranisaeed designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT madkhaliosamaa designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals
AT mohansyam designphysicochemicalcharacterisationandinvitrocytotoxicityofcisplatinloadedpegylatedchitosaninjectablenanosubmicroncrystals